Human Molecular Genetics Advance Access originally published online on December 22, 2004
Human Molecular Genetics 2005 14(4):475-482; doi:10.1093/hmg/ddi043
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 14, No. 4 © Oxford University Press 2005; all rights reserved
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis
British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada
Received October 4, 2004; Revised December 8, 2004; Accepted December 15, 2004
Lung cancer is the leading cause of cancer death in North America. Despite advances in lung cancer treatment, the overall 5 year survival rate for those diagnosed with the disease is bleak presumably due to the late stage of diagnosis. Owing to the difficulty of early detection, preneoplastic specimens are rare. However, studying both preinvasive and invasive stages of disease is necessary to fully understand lung cancer progression. Aberration of chromosome arm 1p is common in lung and other cancers. In this study, we used a genomic array with complete tiling coverage of 1p to profile preinvasive and invasive squamous non-small cell lung carcinoma samples. With this technology, multiple novel submegabase alterations were identified. Three of the 1p alterations harbored genes belonging to gene families known to be involved in cancer development through either the Wnt or the Notch developmental pathways. Our finding of a 0.4 Mb amplified region at 1p36.12 containing WNT4 in preinvasive lung cancer, coupled with the identification of three additional alterations in invasive tumors that also contain genes related to the Notch and Wnt pathways, strongly suggests an intricate role of these pathways in early and late stages of lung cancer development. Furthermore, ectopic expression of DVL1, LRP8 and Notch2 in malignant lung tissue validates the biological impact of these genetic alterations. Importantly, this implication of pathways known only to be activated in fetal lung development lends support to the proposed model of lung cancer ontology whereby tumors arise from dysregulated pleuripotent stem cells.
* To whom correspondence should be addressed at: BC Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada. Tel: +1 6048776149; Fax: +1 60487760002421; Email: cgarnis{at}bccrc.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J. Ross, L. A. Dailey, L. E. Brighton, and R. B. Devlin Transcriptional Profiling of Mucociliary Differentiation in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 169 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hardman, A. Waite, L. Zeef, M. Burow, T. Nakayama, and G. S. Ashcroft Macrophage Migration Inhibitory Factor: A Central Regulator of Wound Healing Am. J. Pathol., December 1, 2005; 167(6): 1561 - 1574. [Abstract] [Full Text] [PDF]
|
|